Background A 2017 systematic review (SR) identified 59 studies examining gabapentinoid
(pregabalin and gabapentin) misuse/abuse. Evidence of gabapentinoid misuse/abuse has …

Background Gabapentinoid (pregabalin and gabapentin) abuse is increasingly being
reported. Objective To assess the extent of gabapentinoid abuse, characteristics of typical …

In the last ten years, gabapentin and pregabalin have been becoming dispensed broadly
and sold on black markets, thereby, exposing millions to potential side-effects. Meanwhile …

Abstract Background and Aims Since its market release, gabapentin has been presumed to
have no abuse potential and subsequently has been prescribed widely off‐label, despite …

Novel psychoactive substances include synthetic cannabinoids, cathinone derivatives,
psychedelic phenethylamines, novel stimulants, synthetic opioids, tryptamine derivatives …

Introduction The gabapentinoids pregabalin and gabapentin are being increasingly
prescribed for a range of clinical conditions. Recently, although gabapentinoids at …

This review summarizes current evidence on the abuse and misuse of the gabapentinoids
pregabalin and gabapentin. Pharmacovigilance studies, register-based studies, surveys …

Background Several case reports and epidemiological studies have raised concern about
the abuse potential of pregabalin, the use of which has increased substantially over the last …

Objective: To identify case reports and studies regarding patients who abused, became
dependent on, or experienced withdrawal from gabapentin. Data Sources: A PubMed …

The current work is targeted to review the risks of gabapentin misuse, its potential
interactions with other drugs, side effects and use contraindications. This review consists of …